Effects of Integrase Strand Transfer Inhibitors Versus Non-INSTI Regimen Exposures in Pregnancy Outcomes, Maternal Weight Gain, and Human Immunodeficiency Virus Viral Suppression
{{output}}
Background: Integrase strand transfer inhibitors (INSTIs) with and without tenofovir alafenamide fumarate (TAF) are recommended in first-line regimens for pregnant people living with human immunodeficiency virus (PWH), with mixed data emerging on pregnancy out... ...
